Due to a recent outbreak, influenza and COVID-19 have been in the forefront of people’s minds. Influenza, in particular, continues to affect all age groups despite it being late in the typical season. In this podcast episode, we discuss the entire course of this disease process; from positive nasopharyngeal swab to downstream ARDS and the complex ventilator management associated with refractory hypoxemia.
Table 1
Groups at risk of influenza complications
| Unvaccinated infants aged 12–24 months |
| Persons with asthma or other chronic pulmonary diseases such as cystic fibrosis in children or chronic obstructive pulmonary disease in adults |
| Persons with hemodynamically significant cardiac disease |
| Persons who have immunosuppressive disorders or who are receiving immunosuppressive therapy HIVinfected persons |
| Persons with sickle-cell anemia and other hemoglobinopathies |
| Persons with diseases requiring long-term aspirin therapy such as rheumatoid arthritis |
| Persons with chronic renal dysfunction |
| Persons with cancer |
| Persons with chronic metabolic diseases such as diabetes mellitus Persons with neuromuscular disorders, seizure disorders, or cognitive dysfunction—which may compromise the handling of respiratory secretions |
| Adults aged>65 years |
| Residents of any age of nursing homes or other long-term care institutions |
https://www.cdc.gov/flu/professionals/acip/background-epidemiology.htm
https://jamanetwork.com/journals/jama/article-abstract/2757578
https://www.jems.com/2019/05/13/succinylcholine-vs-rocuronium-battle-of-the-rsi-paralytics/
